Physicians' social networks in China


Published on

An overview of the opportunities that physicians' social networks may offer pharmaceutical companies as an emergent new engagement channel in China. Includes analyses of current physicians' social networks in China, physicians' social networks as a global phenomenon, key learnings and Chinese scenarios. Presented at conferences in Shanghai in 2009 and Singapore in 2010. This version presented at EyeforPharma's Sales & Marketing in China for Pharma conference, 3 - 4 December 2009, Shanghai.

Published in: Health & Medicine, Business
1 Comment
No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Physicians' social networks in China

  1. 1. Physicians’ Social Networks in China An Emergent New Engagement Channel for Pharma? Len Starnes Head of Digital Marketing & Sales General Medicine Len Starnes Head of Digital Marketing & Sales General Medicine Bayer Schering Pharma Sales & Marketing in China for Pharma 3 – 4 December 2009 Shanghai
  2. 2. Agenda <ul><li>China’s social internet </li></ul><ul><li>The Big Bang </li></ul><ul><li>Global dimensions </li></ul><ul><li>Anatomies </li></ul><ul><li>Key learnings </li></ul><ul><li>Chinese scenarios </li></ul>
  3. 3. China’s social internet Physicians’ social networks in China
  4. 4. In China the internet and social are synonymous ‘ 92% of Chinese Netizens use social media compared with 76% in the US’* *The Great Social Wall of China: Netpop Research, Shanghai, 2009,
  5. 5. *Manhattan Research, Taking the Pulse Asia v9.0, 2009 % physicians owning Chinese physicians becoming tech-savvy
  6. 6. How many Chinese physicians online? Manhattan Research 60% Zhan Gao Haoyisheng 90% 84% Based on data from CIC Shanghai & PRC Ministry of Health 2008 卫生部政府信息公开专题 97% Bayer Healthcare China: 5 major cities
  7. 7. *Manhattan Research, Taking the Pulse Asia v9.0, 2009 Chinese physicians participate in all types of social media 78% Read posts from colleagues on bulletin boards, in chat rooms and on blogs*
  8. 8. *Manhattan Research, Taking the Pulse Asia v9.0, 2009 % physicians agreeing The internet is essential to my professional practice* Distinct similarities worldwide
  9. 9. *Manhattan Research, Taking the Pulse Asia v9.0, 2009 % physicians agreeing Internet is a crucial tool for Chinese physicians
  10. 10. *Manhattan Research, Taking the Pulse Asia v9.0, 2009 % physician respondents Demand for physicians’ social networks high across Asia
  11. 11. Good Doctor’s Forum 好医生论坛 With thanks to Mudskipper Business Consulting Shanghai > 418,000 members
  12. 12. China Asthma Alliance 中国 哮喘联盟 With thanks to Mudskipper Business Consulting Shanghai > 7,200 members
  13. 13. 1.7m members - 50% physicians - 30% biomed researchers - 20% medical students With thanks to Kevin Lin, JSure Healthmedia
  14. 14. With thanks to: Mudskipper Business Consulting Shanghai; CIC Shanghai Embryonic characteristics Majority run on public networks (BBS) No authentication, heterogeneous membership Focus on medical information, not community Owners: medical associations, commercial, private No integration with daily practice No compelling community functionality
  15. 15. Physicians’ social networks in China The Big Bang
  16. 16. Transforming the way medical information is exchanged Based on Pfizer/Sermo press release 15 October 2007 The Pfizer-Sermo partnership Pharmaceutical industry Initiating open and honest discussion Medical profession
  17. 17. Setting the pace Daniel Palestrant founder &CEO Partnerships with financial sector & pharma US$ 40m VC Continuously evolving services Free lunches for MIT students
  18. 18. Global dimensions Physicians’ social networks in China
  19. 19. USA Dominant Sermo Physician Connect Student Doctor Network Healtheva Relaxdoc SocialMD Sosido Clinical Village iMedExchange Tiromed Ozmosis Medical Plexus Within3 Rad Rounds MedTrust MedicSpeak Peerclip Syndicom Spineconnect QuantiaMD MDsConnect Number of networks Diversity of networks Business models Attracting VC Pharma participation
  20. 20. 110,000 members each
  21. 21. Europe Heterogeneous doc2doc (Global) (UK) OnMedica (UK) Coliquio (D, CH, AT) DocCheck Faces (Int’l) DocCheck Faces(D) DocCheck Faces (F) DocCheck Faces (ES) DocCheck Faces (IT) Dooox (D) Esanum (D) Esanum (ES) Esanum (IT) Esanum (CH) Esanum (AT) Esanum (F) Sermo (2009/10?) UK and Germany lead Fewer players Catching up with USA
  22. 22. 15,000 members Open and closed areas Integrated with BMJ Group medical content Global 130 countries
  23. 23. Focuses on D, CH, AT 16,000 members Partnership with leading German medical journal Ärzte Zeitung Expanding to other EU countries 2010
  24. 24. Asia Pacific Emerging opportunities High growth rates Significant membership numbers Good Doctor’s Forum (CN) China Asthma Alliance (CN) (CN) China (CN) Orthochina (CN) Public networks (BBS) (CN) Doctors Hangout (IN) Doctor.VG (IN) Medtitans (IN) Protomedica (IN) HelloDr (IN) Smartdoc (IN) (JP) MedPeer (JP) Carenet (JP) NM Online (JP) MT Pro (JP) Medigate( KR) Misc medical news sites (KR) Australian Doctor (AU) New Media Medicine (NZ)
  25. 25., Japan Authenticated physicians 177,000 members
  26. 26. Medigate, South Korea Authenticated physicians 67,000 members
  27. 27. DoctorsHangout, India Physicians & medical students 14,000 members
  28. 28. Focus on medical students 60,000 members 500,000 posts Medical students today… members of physicians’ SNs tomorrow
  29. 29. Anatomies Physicians’ social networks in China
  30. 30. Authentication All specialities Includes pharma 1 st dimension taxonomy Authentication Single speciality Includes pharma Authentication All specialities Excludes pharma No authentication All specialities Inc & excl pharma
  31. 31. Pure play Social network only Sermo Ozmosis Coliquio 2 nd dimension taxonomy Hybrid Social network + online med resource Physician Connect doc2doc
  32. 32. Participation by scientific liaison staff (MDs & PhDs) in community discussions Post information and services germane to discussions Post questions to a specialist community Conduct surveys Establish panels based on pre-selected criteria Unmet needs Treatment trends Drug usage monitoring Future Rx volume Unknown side-effects Off-label usage Early identification of critical issues Engagement Research Observation Pharma partnering options
  33. 33. Key learnings Physicians’ social networks in China
  34. 34. Membership growing everywhere
  35. 35. Sustained growth in USA Physicians in 2012: Manhattan Research, Taking the Pulse v9.0, 2009 Already using + very interested + somewhat interested % respondents Physician Online Communities: Social Networking Manhattan Research, Taking the Pulse v8.0, 2008
  36. 36. Source: Coliquio
  37. 37. Not just younger physicians
  38. 38. Sermo members markedly older than average internet Age of Sermo users Percent total Source: Sermo
  39. 39. Substantial pharma interest
  40. 41. Physicians welcome pharma participation … but only on their terms. No selling or advertising
  41. 42. Welcome interacting with pharma Physician Online Communities: Social Networking Manhattan Research, Taking the Pulse v8.0, 2008 I am interested in interacting with pharma, biotech and device companies on physicians’ only SNs 59% Strongly agree + agree 41% Strongly disagree + disagree
  42. 43. Finding Pfizer physicians able to talk openly and honestly is a problem Welcome open discussions with Pfizer* Prime interest is driving P2P and Pfizer doctor to non-Pfizer doctor discussions *Reported at Health 2.0 conference, San Francisco, 22 – 23 October 2008
  43. 44. Pharma’s challenges mainly internal
  44. 45. Marketing Medical & Scientific Marketing Research Cross-disciplinary collaboration essential
  45. 46. Regulatory issues can be pragmatically resolved
  46. 47. Real-time poll update:
  47. 48. Physicians’ social networks in China Chinese scenarios
  48. 49. Next 5 years Highly e-savvy physicians Authenticated physicians-only SNs Routine use & integration of physicians’ SNs Multi-channel pharma engagement models Physicians expecting pharma SM engagement Explicit & globally-unified SM regulatory framework
  49. 50. Establish authenticated trusted communities Develop hybrid models integrating community & authoritative medical resources Initiate speciality networks facilitating dialogue between physicians & pharma Create communities with services & functionalities supporting clinical practice Opportunities
  50. 51. Shifts focus from selling to dialogue Builds better relationships with physicians Reduces reliance on sales forces Combats increasing regulatory restrictions Benefits for pharma
  51. 52. Catch the wave
  52. 53. <ul><li>Head of Digital Marketing & Sales General Medicine Bayer Schering Pharma </li></ul><ul><li>E: [email_address] Lkn: Twt: Ssh: T: + 49 30 4681 4877 M: + 49 175 438 4521 I: </li></ul>Len Starnes
  53. 54. Acknowledgements <ul><li>The author would like to thank the following for their help and advice in developing this presentation: </li></ul><ul><li>Mark Bard, Manhattan Research, New York </li></ul><ul><li>Sam Flemming, CIC, Shanghai </li></ul><ul><li>Richard Allcorn, Amiculum Ltd, UK </li></ul><ul><li>Mudskipper Business Consulting, Shanghai </li></ul><ul><li>Zhan Gaoz, Haoyisheng, Beijing </li></ul><ul><li>Felix Rademacher, Coliquio, Germany </li></ul><ul><li>Chris Cooper, EPG Online, UK </li></ul><ul><li>Simon Levy & Simon Walker, doc2doc, London </li></ul><ul><li>Kevin Lin, JSure HealthMedia, Shanghai </li></ul>